Showing results (111-120 of 214) with videos related to

Sort By:
Pageof 22
Clinical Chemistry|May 1, 1990
Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasmaS Munkvad, J Jespersen, J Gram, et al.
Journal of Thrombosis and Haemostasis : JTH|October 15, 2010
The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers--two independent studiesL Poller, S Ibrahim, M Keown, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 2, 2001
In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. possible implications for measurements in vivo after heparin therapyE M Bladbjerg, L F Larsen, P Ostergaard, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young womenK R Petersen, J Sidelmann, S O Skouby, et al.
American Journal of Obstetrics and Gynecology|February 13, 1999
Effects of hormone replacement therapy on hemostatic cardiovascular risk factorsL F Andersen, J Gram, S O Skouby, et al.
Thrombosis and Haemostasis|November 15, 1993
Multicentre evaluation of commercial kit methods: plasminogen activator inhibitor activityJ Gram, P J Declerck, J Sidelmann, et al.
Journal of Internal Medicine|February 26, 2000
Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control studyJ Gram, E M Bladbjerg, L Møller, et al.
Coronary Artery Disease|April 1, 1993
Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activatorJ Gram, S Munkvad, F W Leebeek, et al.
Thrombosis and Haemostasis|February 1, 1995
Dietary changes in fasting levels of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteinsE M Bladbjerg, T Tholstrup, P Marckmann, et al.
Human Reproduction (Oxford, England)|November 29, 2002
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitorE M Bladbjerg, S O Skouby, L F Andersen, et al.
Pageof 22